Acetic Anhydride → HCID 59577904, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[S:8]([N:11]1[CH2:32][CH2:31][C:14]2([C:18](=[O:19])[N:17]([C:20]3[CH:25]=[CH:24][C:23]([CH2:26][C:27]([NH:29][OH:30])=[NH:28])=[CH:22][CH:21]=3)[CH2:16][CH2:15]2)[CH2:13][CH2:12]1)(=[O:10])=[O:9].[C:33](OC(=O)C)(=O)[CH3:34]>>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[S:8]([N:11]1[CH2:12][CH2:13][C:14]2([C:18](=[O:19])[N:17]([C:20]3[CH:25]=[CH:24][C:23]([CH2:26][C:27]4[N:28]=[C:33]([CH3:34])[O:30][N:29]=4)=[CH:22][CH:21]=3)[CH2:16][CH2:15]2)[CH2:31][CH2:32]1)(=[O:10])=[O:9]Participants
3
Procedure
Above 2-{4-[8-(2-chloro-benzenesulfonyl)-1-oxo-2,8-diaza-spiro[4.5]dec-2-yl]-phenyl}-N-hydroxy-acetamidine (150 mg) were treated at RT with acetic anhydride (40 ml) and then refluxed for 30 minutes. The reaction mixture was concentrated in vacuo, the residue purified by chromatography on silica gel to give the desired 8-(2-chloro-benzenesulfonyl)-2-[4-(5-methyl-[1,2,4]oxadiazol-3-ylmethyl)-phenyl]-2,8-diaza-spiro[4.5]decan-1-one as a light yellow crystalline solid. MS (ESI): 502.1 (MH+).
Workup
- temperaturerefluxed for 30 minutes
- concentrationThe reaction mixture was concentrated in vacuo
- customthe residue purified by chromatography on silica gel
Sources & evidence
- ORD record
- ord-0ee9656c7dcd4df59877f3e1bf683820
- Source dataset
- uspto-grants-2012_12
- Patent number
- US08329904B2
Reaction notes
Loading…